ESC Premium Access

Treatment intensity in primary and secondary prevention? The role of precision medicine.


About the speaker

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
36 presentations
1 follower

3 more presentations in this session

Should we address other lipid/lipoproteins besides LDL-C?

Speaker: Professor R. Frikke-Schmidt (Copenhagen, DK)


When should we add PCSK-9 inhibitors?

Speaker: Professor S. Nicholls (Melbourne, AU)


Is there a place for anti-inflammatory medication in clinical practice?

Speaker: Professor K. Ray (London, GB)


Access the full session

Lipid-lowering therapy: how to tailor treatment to your patient

Speakers: Professor J. Deanfield, Professor R. Frikke-Schmidt, Professor S. Nicholls, Professor K. Ray

About the event


ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk